Paper Details

Paper Title

Metformin is associated with reduced COVID-19 severity in patients with prediabetes.

Paper Journal Title

Diabetes Res Clin Pract

Paper Citation Count

Paper Publication Year

2022

Bio Mention

COVID-19, ED, Metformin, PCOS, diabetes, levothyroxine, metformin, ondansetron, patients, polycystic ovary syndrome, prediabetes

Mesh Descriptor

COVID-19, Female, Humans, Hypoglycemic Agents, Metformin, Polycystic Ovary Syndrome, Prediabetic State, Retrospective Studies, Thyroxine

Author Name	Affiliation
Lauren E Chan	College of Public Health and Human Sciences, Oregon State University
Bryan Laraway	University of Colorado Anschutz Medical Campus
Ben Coleman
Hannah Blau
Adnin Zaman	University of Colorado Anschutz Medical Campus
Nomi L Harris	Lawrence Berkeley National Laboratory
Nomi L Harris	Lawrence Berkeley National Laboratory
Kenneth J Wilkins	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Blessy Antony	Virginia Tech
Michael Gargano
Giorgio Valentini	Universita degli Studi di Milano
David Sahner
Melissa A Haendel	University of Colorado Anschutz Medical Campus
Melissa A Haendel	University of Colorado Anschutz Medical Campus
Peter N Robinson	USA Institute for Systems Genomics, University of Connecticut
Peter N Robinson	USA Institute for Systems Genomics, University of Connecticut
Carolyn T Bramante	University of Minnesota

Column Actions